A new monoclonal antibody called clesrovimab has been recommended for infants to prevent RSV, stirring debate among health experts and advocates. The FDA approved the treatment just weeks ago.
A child in rural West Texas becomes the first U.S. fatality in the recent measles outbreak, raising concerns about vaccination rates and public health response to preventable diseases.
